CHINOOK THERAPEUTICS INC - COM (KDNY)

CUSIP: 16961L106

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
4,933,068
Share change
+4,933,068
Total reported value
$11,987,000
Price per share
$2.43
Number of holders
5
Value change
+$11,987,000
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 16961L106?
CUSIP 16961L106 identifies KDNY - CHINOOK THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHINOOK THERAPEUTICS INC - COM (KDNY) as of Q3 2020

As of 30 Sep 2020, CHINOOK THERAPEUTICS INC - COM (KDNY) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,933,068 shares. The largest 5 holders included BAILLIE GIFFORD & CO, Ensign Peak Advisors, Inc, PANAGORA ASSET MANAGEMENT INC, PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO, and NISA INVESTMENT ADVISORS, LLC. This page lists 5 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.